VanEck Associates’s Compugen CGEN Stock Holding History

VanEck Associates’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-21,426	Closed	-$69K	–	1385
2022 Q1	$69K	Buy	21,426 +120	+0.6%	+$405	﹤0.01%	1268
2021 Q4	$92K	Sell	21,306 -864	-4%	-$4.67K	﹤0.01%	1259
2021 Q3	$132K	Sell	22,170 -1,782	-7%	-$11.9K	﹤0.01%	1096
2021 Q2	$198K	Buy	23,952 +2,174	+10%	+$17.6K	﹤0.01%	1004
2021 Q1	$187K	Buy	+21,778	New	+$242K	﹤0.01%	950
2014 Q3	–	Sell	-21,615	Closed	-$194K	–	709
2014 Q2	$194K	Buy	21,615 +5,032	+30%	+$45.3K	﹤0.01%	612
2014 Q1	$174K	Buy	16,583 +3,441	+26%	+$37.9K	﹤0.01%	598
2013 Q4	$118K	Buy	+13,142	New	+$128K	﹤0.01%	600

Other funds holding CGEN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

VanEck Associates's CGEN Position: Q2 2022 in Review

VanEck Associates sold out of Compugen (CGEN) in Q2 2022, closing a stake of 21,426 shares — an estimated $69K sold.

VanEck Associates first reported a position in CGEN in Q4 2013 and held it in 8 quarters. The position peaked at $198K in Q2 2021. 89 funds tracked by Wall St. Rank hold CGEN as of Q2 2022.

VanEck Associates reported no remaining Compugen position as of Q2 2022 after selling out during the quarter.
VanEck Associates sold 21,426 Compugen shares in Q2 2022, an estimated $69K.
VanEck Associates first reported a position in Compugen in Q4 2013 and held it in 8 quarters.
VanEck Associates's Compugen position peaked at $198K in Q2 2021.
89 funds tracked by Wall St. Rank held Compugen as of Q2 2022.

Based on VanEck Associates's 13F filing for Q2 2022, filed 3 Aug 2022.